Literature DB >> 16221526

Ajoene inhibits both primary tumor growth and metastasis of B16/BL6 melanoma cells in C57BL/6 mice.

Peter Taylor1, Raquel Noriega, Carla Farah, María-Jesús Abad, Miriam Arsenak, Rafael Apitz.   

Abstract

Ajoene is an organosulphur compound derived from garlic with important effects on several membrane-associated processes such as platelet aggregation, as well as being cytotoxic for tumor cell lines in vitro. In the present study, we investigated the effect of ajoene on different cell types in vitro, as well as its inhibitory effects on both primary tumors and metastasis in a mouse model. We found ajoene to inhibit tumor cell growth in vitro, but also to inhibit strongly metastasis to lung in the B16/BL6 melanoma tumor model in C57BL/6 mice. As far as we are aware, this is the first report of the anti-metastatic effect of ajoene. Ajoene also inhibited tumor-endothelial cell adhesion, as well as the in vivo TNF-alpha response to lipopolysaccharide. Possible mechanisms of its antitumoral activity are discussed in the light of these results.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16221526     DOI: 10.1016/j.canlet.2005.08.022

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  13 in total

1.  Anti-inflammatory activity of sulfur-containing compounds from garlic.

Authors:  Da Yeon Lee; Hua Li; Hyo Jin Lim; Hwa Jin Lee; Raok Jeon; Jae-Ha Ryu
Journal:  J Med Food       Date:  2012-10-11       Impact factor: 2.786

2.  ROS-mediated activation of JNK/p38 contributes partially to the pro-apoptotic effect of ajoene on cells of lung adenocarcinoma.

Authors:  Yingyi Wang; Zhao Sun; Shuchang Chen; Yuchen Jiao; Chunmei Bai
Journal:  Tumour Biol       Date:  2015-10-14

Review 3.  Molecular targets of nutraceuticals derived from dietary spices: potential role in suppression of inflammation and tumorigenesis.

Authors:  Bharat B Aggarwal; Michelle E Van Kuiken; Laxmi H Iyer; Kuzhuvelil B Harikumar; Bokyung Sung
Journal:  Exp Biol Med (Maywood)       Date:  2009-06-02

Review 4.  Multitargeted prevention and therapy of cancer by diallyl trisulfide and related Allium vegetable-derived organosulfur compounds.

Authors:  Anna A Powolny; Shivendra V Singh
Journal:  Cancer Lett       Date:  2008-06-24       Impact factor: 8.679

Review 5.  Next-Gen Therapeutics for Skin Cancer: Nutraceuticals.

Authors:  Annapoorna Sreedhar; Jun Li; Yunfeng Zhao
Journal:  Nutr Cancer       Date:  2018-05-15       Impact factor: 2.900

6.  Systemic approaches identify a garlic-derived chemical, Z-ajoene, as a glioblastoma multiforme cancer stem cell-specific targeting agent.

Authors:  Yuchae Jung; Heejoo Park; Hui-Yuan Zhao; Raok Jeon; Jae-Ha Ryu; Woo-Young Kim
Journal:  Mol Cells       Date:  2014-07-31       Impact factor: 5.034

Review 7.  Molecular mechanisms of garlic-derived allyl sulfides in the inhibition of skin cancer progression.

Authors:  Hsiao-Chi Wang; Jung Pao; Shuw-Yuan Lin; Lee-Yan Sheen
Journal:  Ann N Y Acad Sci       Date:  2012-10       Impact factor: 5.691

8.  The Cytotoxicity of the Ajoene Analogue BisPMB in WHCO1 Oesophageal Cancer Cells Is Mediated by CHOP/GADD153.

Authors:  Vuyolwethu Siyo; Georgia Schäfer; Roger Hunter; Andriy Grafov; Iryna Grafova; Martin Nieger; Arieh A Katz; M Iqbal Parker; Catherine H Kaschula
Journal:  Molecules       Date:  2017-05-28       Impact factor: 4.411

9.  In Vivo Antitumor Effects of MK615 Led by PD-L1 Downregulation.

Authors:  Masashi Yanaki; Masayuki Kobayashi; Atsushi Aruga; Minoru Nomura; Makoto Ozaki
Journal:  Integr Cancer Ther       Date:  2018-04-18       Impact factor: 3.279

10.  The garlic compound ajoene covalently binds vimentin, disrupts the vimentin network and exerts anti-metastatic activity in cancer cells.

Authors:  Catherine H Kaschula; Rosanna Tuveri; Ellen Ngarande; Kevin Dzobo; Christopher Barnett; Daniel A Kusza; Lisa M Graham; Arieh A Katz; Mohamed Suhail Rafudeen; M Iqbal Parker; Roger Hunter; Georgia Schäfer
Journal:  BMC Cancer       Date:  2019-03-20       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.